Yungjin Pharm. Co., Ltd.

KSE 003520.KS

Yungjin Pharm. Co., Ltd. EPS (Diluted) for the year ending December 31, 2023: USD -0.02

Yungjin Pharm. Co., Ltd. EPS (Diluted) is USD -0.02 for the year ending December 31, 2023, a 82.84% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Yungjin Pharm. Co., Ltd. EPS (Diluted) for the year ending December 31, 2022 was USD -0.09, a -78.96% change year over year.
  • Yungjin Pharm. Co., Ltd. EPS (Diluted) for the year ending December 31, 2021 was USD -0.05, a -7,809.87% change year over year.
  • Yungjin Pharm. Co., Ltd. EPS (Diluted) for the year ending December 31, 2020 was USD -0.00, a -102.83% change year over year.
  • Yungjin Pharm. Co., Ltd. EPS (Diluted) for the year ending December 31, 2019 was USD 0.02, a 180.35% change year over year.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
Loading...
KSE: 003520.KS

Yungjin Pharm. Co., Ltd.

CEO Mr. Chae-Joon Lee
IPO Date Jan. 8, 2001
Location South Korea
Headquarters 13, Olympic-ro 35da-gil
Employees 574
Sector Health Care
Industries
Description

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea. It provides cephalosporin antibiotic, antipsychotic, cardiovascular, and nutrition products. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. is a subsidiary of KT&G Corporation.

Similar companies

000100.KS

Yuhan Corporation

USD 89.21

-4.31%

003000.KS

Bukwang Pharmaceutical Co., Ltd.

USD 3.32

0.12%

006280.KS

Green Cross Corporation

USD 108.37

-2.33%

003850.KS

Boryung Corporation

USD 7.02

1.13%

069620.KS

Daewoong pharmaceutical Co.,Ltd

USD 89.82

-0.84%

StockViz Staff

January 15, 2025

Any question? Send us an email